Vystar Valuation Multiples

Discover Vystar's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Highlander Enterprise, Australian Silica Quartz, Svenska Aerogel, POLYDUCT Plastic and more.

Vystar Overview

About Vystar

Vystar Corp is engaged in the rubber and plastic products market. It develops technology to produce Vytex Natural Rubber Latex which reduces antigenic protein and non-rubbers in natural rubber latex to undetectable levels. The company's products and services include Natural Rubber Latex and clinical sleep diagnostics and durable medical equipment. The company derives revenue from sales of or license fees of Vytex NRL raw material to manufacturers and distributors of rubber and rubber end products.


Founded

2003

HQ

United States

Employees

1

Website

vytex.com

Financials (FY)

Revenue: $55K
EBITDA: ($1M)

EV

$5M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vystar Financials

Vystar reported last fiscal year revenue of $55K and negative EBITDA of ($1M).

In the same fiscal year, Vystar generated $32K in gross profit, ($1M) in EBITDA losses, and had net loss of ($2M).


Vystar P&L

In the most recent fiscal year, Vystar reported revenue of $55K and EBITDA of ($1M).

Vystar is unprofitable as of last fiscal year, with gross margin of 58%, EBITDA margin of (1933%), and net margin of (2794%).

See analyst estimates for Vystar
Last FY202320242025202620272028
Revenue$55K$526K$136K$55K
Gross Profit$32K$385K$70K$32K
Gross Margin58%73%51%58%
EBITDA($1M)($849K)($1M)($1M)
EBITDA Margin(1933%)(162%)(993%)(1933%)
EBIT Margin(1935%)(293%)(1116%)(1935%)
Net Profit($2M)($5M)$760K($2M)
Net Margin(2794%)(997%)559%(2794%)
Net Debt$998K---

Financial data powered by Morningstar, Inc.

Vystar Stock Performance

Vystar has current market cap of $4M, and enterprise value of $5M.

Market Cap Evolution


Vystar's stock price is $0.17.

Vystar share price increased by 24.5% in the last year.

Vystar has an EPS (earnings per share) of $-0.06.

See more trading valuation data for Vystar
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$4M0.1%0.0%-39.3%24.5%$-0.06

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vystar Valuation Multiples

Vystar trades at 96.1x EV/Revenue multiple, and (5.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for Vystar

Vystar Financial Valuation Multiples

As of July 2, 2026, Vystar has market cap of $4M and EV of $5M.

Vystar has a P/E ratio of (2.7x).

Last FY202320242025202620272028
EV/Revenue96.1x10.0x38.7x96.1x
EV/EBITDA(5.0x)(6.2x)(3.9x)(5.0x)
EV/EBIT(5.0x)(3.4x)(3.5x)(5.0x)
EV/Gross Profit165.5x13.7x75.6x165.5x
P/E(2.7x)(0.8x)5.5x(2.7x)
EV/FCF(29.2x)(11.9x)(52.7x)(29.2x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vystar Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Vystar Margins & Growth Rates

In the most recent fiscal year, Vystar reported gross margin of 58%, EBITDA margin of (1933%), and net margin of (2794%).

See estimated margins and future growth rates for Vystar

Vystar Margins

Last FY20242025202720282029
Gross Margin58%51%58%
EBITDA Margin(1933%)(993%)(1933%)
EBIT Margin(1935%)(1116%)(1935%)
Net Margin(2794%)559%(2794%)
FCF Margin(329%)(74%)(329%)

Vystar Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(74%)(60%)
Gross Profit Growth(82%)(54%)
EBITDA Growth59%(22%)
EBIT Growth(1%)(30%)
Net Profit Growth(114%)(302%)
FCF Growth(77%)80%

Data powered by FactSet, Inc. and Morningstar, Inc.

Vystar Operational KPIs

Vystar's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $1.1M for the same period.

Access forward-looking KPIs for Vystar
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$1.1M---
S&M Expenses to Revenue8%3%1%8%
G&A Expenses to Revenue1757%326%1085%1757%
Opex to Revenue1993%366%1167%1993%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Highlander Enterprise33.1x-43.1x-
Australian Silica Quartz----
Svenska Aerogel9.2x-(1.8x)-
POLYDUCT Plastic0.2x-1.9x-
OrganoClick1.2x-(9.5x)-
EcoRub3.1x-(6.0x)-
Nattaro Labs6.1x-(4.8x)-
Soprocal Calerias0.2x-(2.5x)-

This data is available for Pro users. Sign up to see all Vystar competitors and their valuation data.

Start Free Trial

Acquisitions by Vystar

Vystar has acquired 2 companies to date.

Last acquisition by Vystar was on May 28th 2019. Vystar acquired Fluid Energy Conversion for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Vystar

Fluid Energy Conversion
NHS Holdings
Description
Fluid Energy Conversion is a U.S.-based green technology company utilizing patented acoustic systems to convert sound energy for industrial applications. Their devices apply ultrasonic waves to disinfect water, enhance irrigation efficiency, and accelerate chemical processes in wastewater treatment. Headquartered in Boulder, Colorado, the firm targets municipal utilities and agriculture with scalable reactors deployed in North America.
NHS Holdings is the exclusive U.S. distributor of Vytex natural rubber latex foam produced by Vystar Corporation for manufacturers in bedding, footwear, and medical applications. Based in Georgia, the company facilitates supply of this low-protein, hypoallergenic latex alternative to major producers seeking sustainable, non-sensitizing materials. Vytex foam reduces antigenic proteins by over 90 percent compared to standard latex, serving markets that prioritize allergen-free products.
HQ CountryUnited StatesUnited States
HQ City
Palm Springs, CA
Wilmington, DE
Deal Date28 May 20199 Jan 2018
Valuationundisclosed$1M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Vystar acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vystar

When was Vystar founded?Vystar was founded in 2003.
Where is Vystar headquartered?Vystar is headquartered in United States.
How many employees does Vystar have?As of today, Vystar has over 1 employees.
Is Vystar publicly listed?Yes, Vystar is a public company listed on OTCM.
What is the stock symbol of Vystar?Vystar trades under VYST ticker.
When did Vystar go public?Vystar went public in 2009.
Who are competitors of Vystar?Vystar main competitors include Highlander Enterprise, Australian Silica Quartz, Svenska Aerogel, POLYDUCT Plastic, OrganoClick, EcoRub, Nattaro Labs, Soprocal Calerias, XP Chemistries, Directa Plus.
What is the current market cap of Vystar?Vystar's current market cap is $4M.
What is the current revenue of Vystar?Vystar's last fiscal year revenue is $55K.
What is the current EV/Revenue multiple of Vystar?Current revenue multiple of Vystar is 96.1x.
Is Vystar profitable?No, Vystar is not profitable.
How many companies Vystar has acquired to date?As of July 2026, Vystar has acquired 2 companies.
What was the largest acquisition by Vystar?$1M acquisition of NHS Holdings on 9th January 2018 was the largest M&A Vystar has done to date.
What companies Vystar acquired?Vystar acquired NHS Holdings and Fluid Energy Conversion.
In how many companies Vystar has invested to date?Vystar hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Vystar

Lists including Vystar

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial